Cargando…
Structural basis for activation of the therapeutic l-nucleoside analogs 3TC and troxacitabine by human deoxycytidine kinase
l-nucleoside analogs represent an important class of small molecules for treating both viral infections and cancers. These pro-drugs achieve pharmacological activity only after enzyme-catalyzed conversion to their tri-phosphorylated forms. Herein, we report the crystal structures of human deoxycytid...
Autores principales: | Sabini, Elisabetta, Hazra, Saugata, Konrad, Manfred, Burley, Stephen K., Lavie, Arnon |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1802566/ https://www.ncbi.nlm.nih.gov/pubmed/17158155 http://dx.doi.org/10.1093/nar/gkl1038 |
Ejemplares similares
-
Targeted Delivery of Deoxycytidine Kinase to Her2-Positive Cells Enhances the Efficacy of the Nucleoside Analog Fludarabine
por: Koduvayur, Sujatha P., et al.
Publicado: (2016) -
Overexpression of MRP4 (ABCC4) and MRP5 (ABCC5) confer resistance to the nucleoside analogs cytarabine and troxacitabine, but not gemcitabine
por: Adema, Auke D, et al.
Publicado: (2014) -
A Humanized Yeast Phenomic Model of Deoxycytidine Kinase to Predict Genetic Buffering of Nucleoside Analog Cytotoxicity
por: Santos, Sean M., et al.
Publicado: (2019) -
A study of 7-deaza-2′-deoxyguanosine–2′-deoxycytidine base pairing in DNA
por: Ganguly, Manjori, et al.
Publicado: (2007) -
Synergistic activity of troxacitabine (Troxatyl™) and gemcitabine in pancreatic cancer
por: Damaraju, Vijaya L, et al.
Publicado: (2007)